Takeda Pharma FY21 Core Profit Rises

Takeda Pharmaceutical Company Limited (TKPHF.PK,TAK) reported fiscal 2021 core net profit of 663.7 million yen, an increase of 1.3% from prior year. Core earnings per share was 425 yen, up 1.2%.

Fiscal 2021 net profit was 230.1 million yen, a decline of 38.8%. Profit per share was 147 yen, down 38.9%.

Fiscal 2021 core revenue was 3.42 trillion yen, an underlying increase of 7.4%.

In FY2022, Takeda expects continued revenue growth. Core operating profit is expected to reach 1.1 trillion yen, mainly driven by business momentum.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ice Cream maker Ben & Jerry's reportedly filed a lawsuit against parent and British consumer giant Unilever to stop the sale of its Israeli business to a local license-holder Avi Zinger. The company alleged that the decision was made without the approval of its independent board. The judge reportedly denied Ben & Jerry's application for a temporary restraining order against Unilever. J&M Foods is recalling certain Lavender Shortbread Cookies sold through department store chain Target Corp. due to undeclared allergens, the U.S. Food and Drug Administration said. These packages were erroneously packed with Chocolate Chip Cookies and do not disclose the presence of a possible allergen, such as soy or eggs. A multi-state listeria outbreak that has killed one and sickened at least 23 others has been linked to Florida -based Big Olaf Creamery brand ice cream, according to the Centers for Disease Control and Prevention or CDC. The outbreak strain has been reported from 10 states, resulting in 22 hospitalizations. One death has been reported from Illinois.
Follow RTT